Jason Begue, MD
Emergency Medicine · Birmingham, ALNPI 1336120682
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 77.7% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $63 and has fallen 51.0% since, to $31 in 2023.
Across 8 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$99
- AstraZeneca$28
Across 17 payments — averaging $97,063 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1.7M
What the payments were for
- Food & beverage$127100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $99 |
| AstraZeneca(2 entities) | 2 | $28 |
How this compares
$127 in reported general payments places this provider in the 60th percentile of 565 emergency medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $442 |
| Cephalexin | 15 | $130 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $70 |
| Ondansetron OdtOndansetron | 12 | $54 |
| Naproxen | 21 | $54 |
| Cyclobenzaprine Hcl | 18 | $43 |
| Prednisone | 16 | $23 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Birmingham
- James GalbraithBirmingham$74K
- Lauren WalterBirmingham$64K
- Maxwell ThompsonBirmingham$4K
- Paul KivelaBirmingham$2K
- Kevin CopeBirmingham$2K
- Eric YatesBirmingham$2K
- Rafael PeraltaBirmingham$2K
- Elizabeth AdamsBirmingham$1K
- Bryan BalentineBirmingham$1K
- Taylor PayneBirmingham$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.